Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections

The inspection of pharmacovigilance systems is regulated by the Good Pharmacovigilance Practices (GVP) and local laws and regulations. Inspections may be carried out by audit teams of competent authorities as part of regulatory activities or business agreements. So far, there have been no studies de...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Abdrakhmanov, R. N. Alyautdin, A. E. Krasheninnikov, B. K. Romanov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-04-01
Series:Безопасность и риск фармакотерапии
Subjects:
Online Access:https://www.risksafety.ru/jour/article/view/234
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839581790580244480
author M. Abdrakhmanov
R. N. Alyautdin
A. E. Krasheninnikov
B. K. Romanov
author_facet M. Abdrakhmanov
R. N. Alyautdin
A. E. Krasheninnikov
B. K. Romanov
author_sort M. Abdrakhmanov
collection DOAJ
description The inspection of pharmacovigilance systems is regulated by the Good Pharmacovigilance Practices (GVP) and local laws and regulations. Inspections may be carried out by audit teams of competent authorities as part of regulatory activities or business agreements. So far, there have been no studies dealing with rate setting for competent authorities labour costs in connection with onsite or documentary inspections of pharmacovigilance systems.The aim of the study was to develop scientifically valid rate setting criteria for labour costs related to onsite or documentary inspections of pharmacovigilance systems.Materials and methods: the assessment of labour costs was carried out by surveying experts of two Eurasian Economic Union (EAEU) countries who have experience in preparing and conducting evaluation and inspection of pharmacovigilance systems. The calculation of the experts’ time costs was performed automatically using the CrocoTime software. The expected workload for experts in 2022 was estimated based on the reports over the last 5 years (2016–2020) containing information on the number of foreign marketing authorisations, and the number of medicines under development according to national registers of medicinal products of the EAEU member states.Results: the study calculated the average expert labour costs and estimated workload for the EAEU competent authorities in 2022. It was demonstrated that the average labour costs are comparable in EAEU member states, however, estimated amount of labour may change (both increase or decrease).Conclusions: further study of rate setting for labour costs related to pharmacovigilance documentary inspections and study of competent authorities staffing could be performed by a dedicated division, e.g. of the Eurasian Academy of Good Practices. A constructive discussion of approaches to the improvement of control over pharmacovigilance systems will increase availability of efficacious and safe medicines of assured quality for the population and help pharmaceutical companies and regulatory authorities manage financial and reputational risks.
format Article
id doaj-art-e95c45c62f6c44d9a551c2829bcd6bc2
institution Matheson Library
issn 2312-7821
2619-1164
language Russian
publishDate 2022-04-01
publisher Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
record_format Article
series Безопасность и риск фармакотерапии
spelling doaj-art-e95c45c62f6c44d9a551c2829bcd6bc22025-08-04T10:16:31ZrusMinistry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»Безопасность и риск фармакотерапии2312-78212619-11642022-04-01101131810.30895/2312-7821-2022-10-1-13-18209Rate Setting for Labour Costs Related to Pharmacovigilance System InspectionsM. Abdrakhmanov0R. N. Alyautdin1A. E. Krasheninnikov2B. K. Romanov3National Center for Expertise of Medicines and Medical DevicesScientific Centre for Expert Evaluation of Medicinal ProductsNational Pharmacovigilance Research Center; N.I. Pirogov Russian National Research Medical UniversityN.I. Pirogov Russian National Research Medical University; Eurasian Academy of Good PracticesThe inspection of pharmacovigilance systems is regulated by the Good Pharmacovigilance Practices (GVP) and local laws and regulations. Inspections may be carried out by audit teams of competent authorities as part of regulatory activities or business agreements. So far, there have been no studies dealing with rate setting for competent authorities labour costs in connection with onsite or documentary inspections of pharmacovigilance systems.The aim of the study was to develop scientifically valid rate setting criteria for labour costs related to onsite or documentary inspections of pharmacovigilance systems.Materials and methods: the assessment of labour costs was carried out by surveying experts of two Eurasian Economic Union (EAEU) countries who have experience in preparing and conducting evaluation and inspection of pharmacovigilance systems. The calculation of the experts’ time costs was performed automatically using the CrocoTime software. The expected workload for experts in 2022 was estimated based on the reports over the last 5 years (2016–2020) containing information on the number of foreign marketing authorisations, and the number of medicines under development according to national registers of medicinal products of the EAEU member states.Results: the study calculated the average expert labour costs and estimated workload for the EAEU competent authorities in 2022. It was demonstrated that the average labour costs are comparable in EAEU member states, however, estimated amount of labour may change (both increase or decrease).Conclusions: further study of rate setting for labour costs related to pharmacovigilance documentary inspections and study of competent authorities staffing could be performed by a dedicated division, e.g. of the Eurasian Academy of Good Practices. A constructive discussion of approaches to the improvement of control over pharmacovigilance systems will increase availability of efficacious and safe medicines of assured quality for the population and help pharmaceutical companies and regulatory authorities manage financial and reputational risks.https://www.risksafety.ru/jour/article/view/234pharmacovigilancepharmacovigilance systemevaluationinspectionrate settinglabour costsgood pharmacovigilance practicegvp
spellingShingle M. Abdrakhmanov
R. N. Alyautdin
A. E. Krasheninnikov
B. K. Romanov
Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
Безопасность и риск фармакотерапии
pharmacovigilance
pharmacovigilance system
evaluation
inspection
rate setting
labour costs
good pharmacovigilance practice
gvp
title Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
title_full Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
title_fullStr Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
title_full_unstemmed Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
title_short Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections
title_sort rate setting for labour costs related to pharmacovigilance system inspections
topic pharmacovigilance
pharmacovigilance system
evaluation
inspection
rate setting
labour costs
good pharmacovigilance practice
gvp
url https://www.risksafety.ru/jour/article/view/234
work_keys_str_mv AT mabdrakhmanov ratesettingforlabourcostsrelatedtopharmacovigilancesysteminspections
AT rnalyautdin ratesettingforlabourcostsrelatedtopharmacovigilancesysteminspections
AT aekrasheninnikov ratesettingforlabourcostsrelatedtopharmacovigilancesysteminspections
AT bkromanov ratesettingforlabourcostsrelatedtopharmacovigilancesysteminspections